BLOODSPOT 17α-HYDROXYPROGESTERONE RADIOIMMUNOASSAY FOR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA AND HOME MONITORING OF CORTICOSTEROID REPLACEMENT THERAPY